AKT1 and schizophrenia: The latter associates with protein kinase B (Akt) and protein phosphatase 2A, causing activation of glycogen synthase kinase-3 (GSK-3); β-arrestin 2/Akt/GSK-3 signaling is implicated in major psychiatric disorders, including BD and schizophrenia [16].